Navigation Links
Amarin Signs Agreement to Acquire Ester Neurosciences
Date:12/5/2007

rice of $1.00 and thus to regain and sustain compliance with this requirement.

Amarin received a notice on December 4, 2007 from The Nasdaq Stock Market indicating that the Company is not in compliance with the $1.00 minimum bid requirement for continued listing and, as a result, the Company's ADSs are subject to delisting, unless the Company requests a hearing by December 11, 2007 in accordance with the Nasdaq Marketplace Rules. The Company intends to request an appeal hearing prior to December 11, 2007 with the Nasdaq Listing Qualification Panel to review the delisting determination. There can be no assurance that the Panel will grant the Company's request for continued listing. If the Panel denies the request, the Company's ADSs will be delisted. The hearing date will be determined by Nasdaq and should occur within 45 calendar days from the request for hearing. Amarin's hearing request will 'stay' the delisting of the Company's ADSs pending the Panel's decision. At the hearing, the Company will be required to provide a plan to regain compliance with the minimum bid price requirement, which will include the Company's plan to seek shareholder approval for the reverse stock split in order to exceed the minimum bid price requirement.

This press release does not constitute a solicitation of proxies for any meeting of shareholders, which can only be made by way of a properly filed meeting notice and related proxy form.

For further information regarding the financial impact of the Ester acquisition on Amarin's historical financial statements, please see the unaudited historical pro forma condensed combined financial statements filed with the SEC in a Report of Foreign Issuer on Form 6-K and available on our website; http://www.amarincorp.com.

Myasthenia Gravis - An Unmet Medical Need

MG is the most common primary disorder of neuromuscular transmission. It is a chronic autoimmune neu
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
2. Amarin to Present at 4th Annual Bio Investor Forum
3. Amarin Announces Initiation of Cardiovascular Development Strategy
4. Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. Monsanto Company Signs Share Subscription Agreement With Devgen
9. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
10. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
11. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...rate research of potential vaccine for low-resourc...Md., Dec. 4 The biotech company Le... organization PATH announced today a partnership t...ine. PATH will initially invest $3 million over 27...lopment of a H5N1 virus-like particle (VLP) protot...
(Date:12/4/2008)...swire-FirstCall/ -- NeoStem, Inc.,(NYSE Alternext...lection,processing and long-term storage of adul...nced that it has reached a major milestone in its ...st ever collection center for collection of,adult...al need in New York,City and has chosen Bruce Yaf...
(Date:12/4/2008)...c. 4 A 60-year-old,pros...e first person in France,to be treated using Rapi...NYSE: VAR ) for fast and precise forms of intens...eatments at the CRLC Val D,Aurelle - Paul Lamarque...faster than conventional IMRT,treatments. Dr. Pas...
(Date:12/4/2008)...s New Trade Name Onrigin(TM) for Laromustine , ...ll/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin B...ted to events in connection with the 50th American...ne Center in San Francisco from December 6-9, 2008..., The Company announced that it would present s...
Breaking Biology Technology:Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4
... was developed at the USDA Forest Products Laborat...ison has been acquired by Xethanol Corp. of New ...TI), was a wholly owned subsidiary of UTEK Corp.,...thanol Corp. is a biotechnology-driven ethanol pro...rough a stock-for-stock exchange. , ,XTI holds a l...
...earch team announced on Sunday they have successfu...in cells, a finding that could affect some of the ...h avenues. But a University of Wisconsin-Madison p...d repercussions. , ,In an article published on the...rchers Chad Cowan, Kevin Eggan and their colleague...
...s made significant progress in improving business ...elieve investment restrictions if the state is to ...te Senate committee heard on Tuesday. , ,"Today it...y than it is to invest in emerging, growth Wiscons...private banker who formerly worked for the Wiscons...
... new UW E-Business Consortium member spotlight ser...y of Wisconsin E-Business Consortium in 2002. , ,...ciate creative appliance design. The brand those v...-Zero Freezer Co. , ,Sub-Zero,s built-in refriger...a home,s dcor, allowing customization to be driven...
Other Biology Technology:Harvard advance improves stem cell research; not a medical revolution 2Regulations still stymie business investment in high-growth companies 2Regulations still stymie business investment in high-growth companies 3Regulations still stymie business investment in high-growth companies 4How Sub-Zero Freezer Co. uses technology to revolutionize customer service 2How Sub-Zero Freezer Co. uses technology to revolutionize customer service 3
(Date:12/3/2008)...R 1, 2008 -- As the United States continues to dev...nergy independence, cellulosic-based ethanol has e...nologies. Corn stover remains the most popular sou... (SOC) associated with the removal of corn fodder ...al and environmental concern. , In the Novembe...
(Date:12/3/2008)...em of children failing to take their medication fo...ackled as part of a new university research projec...ists at The University of Nottingham and The Unive... school children with asthma, diabetes, congenital...riers that prevent them from taking medicines pres...
(Date:12/3/2008)...team of investigators led by researchers at the Ke...n California (USC) has received $19 million in fun... (NIMH) for a groundbreaking effort to collect gen...in order to study the genetic risks for schizophre...Genomic Psychiatry and Massachusetts General Hospi...
(Date:12/3/2008)...E, Mass. Natural changes in voltage that occur ac...powerful controlling factor in the process by whic...earch published by Tufts University scientists. ,...ssor of Biology Michael Levin, and Chair of Biomed...thor) published their paper "Membrane Potential C...
Breaking Biology News(10 mins):Managing carbon loss 2A spoonful of sugar? 2A spoonful of sugar? 3USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 2USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 3New 'control knobs' for stem cells identified 2XTL Biopharmaceuticals to Present at the Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5422 1XTL Biopharmaceuticals to Present at the Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5422 2Going barefoot 3F Beware 21 19426 1Going barefoot 3F Beware 21 19426 2After Effects 3A Giving Back Is Good for You 19422 1After Effects 3A Giving Back Is Good for You 19422 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention Deficit Hyperactivity Disorder 28ADHD 29 2070 1Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention Deficit Hyperactivity Disorder 28ADHD 29 2070 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention Deficit Hyperactivity Disorder 28ADHD 29 2070 3
...such as the Amazon rainforest are home to some 750...5 species in Britain. UCL scientists have ruled ou...of wildlife to climate change, in a paper publishe...e Royal Society B (Biological Sciences). , Instea...eater role in the evolution of species than extern...
...ring an ordinary half-hour argument is enough to s...t least one day, a new study has shown. , Moreove...le toward each other, the delay in that healing pr...dy have major financial implications for medical c..., reported in the current issue of the Archives of...
...tumors by selectively targeting and killing the ma...in the open access journal PLoS Medicine, has appl... (GBM). This is the most aggressive form of brain ...xperienced and killing most patients within a year...zki and colleagues (of The Hebrew University of Je...
...,s AURA satellite, determined the seasonal ozone h...aller than in previous years. , NASA,s 2005 asses... was the first based on observations from the Ozon...craft. Aura was launched in 2004. , This year,s o... peak between September and mid-October, which was...
Other Biology News:Why the Amazon rainforest is so rich in species 2Why the Amazon rainforest is so rich in species 3Stress substantially slows human body's ability to heal 2Stress substantially slows human body's ability to heal 3Preclinical study of a new brain tumor therapy 2NASA's AURA satellite peers into Earth's ozone hole 2
Luminometers
Prolong Gold Antifade Reagent from Invitrogen
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions.
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research
Biology Products: